Your Psychology Psychology articles and news

Drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain, an international study reports, for the first time.

MRI scans of teenagers who had successfully lost weight and kept it off show that they have higher levels of executive function — the ability to process and prioritize competing interests. Executive function is a trait that can be improved, scientists…

Mutations that cause autism in children are connected to a pathway that regulates brain development, scientists have found. The researchers studied a set of well-known autism mutations called copy number variants or CNVs. They investigated when and whe…

How does stress affect our self-confidence when we compete? A new study shows how stress could actually be both a consequence and a cause of social and economic inequality, affecting our ability to compete and make financial decisions.

The right hemisphere may assist a damaged left hemisphere recover visual attention after a stroke, new research suggests. “The results demonstrate that the tasks we do every day change how the brain pays attention to the world around us. By understandi…

Our hearing has a secret bodyguard, a newly discovered connection from the cochlea to the brain that warns of intense incoming noise that causes tissue damage and hearing loss. Scientists believe it’s the ear’s novel pain system designed to protect it …

The brain’s speech area, named after 19th century French physician Pierre Paul Broca, shuts down when we talk out loud, according to a new study that challenges the long-held assumption that ‘Broca’s area’ governs all aspects of speech production.

Nicotine’s primary metabolite supports learning and memory by amplifying the action of a primary chemical messenger involved in both, researchers report. Nicotine has long been known to aid learning and memory, but it’s also highly addictive with a hos…

Two studies examined the effects of tetrabromobisphenol A (TBBPA) at oral doses of 10,100 or 1000 mg/kg bw/day over the course of 2 generations on growth as well as behavioral, neurological and neuropathologic functions in offspring.

Researchers have long sought treatments that can slow the progression of Parkinson’s disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopamine, which the dying nerve cells can no longer produc…